Sector Alterity Therapeutics Limited Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
|
Delayed
Nasdaq
11:53:09 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 2.210 USD | -1.05% |
|
+5.74% | -28.25% |
| 10-05 | Alterity Therapeutics Limited Presents New Analyses of Ath434 Phase 2 Data in Multiple System Atrophy | CI |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.62% | +0.50% | -11.61% | +12.26% | +56.67% | +33.92% | +60.07% | +2.90% | - | 64.38B | |
| +0.35% | +3.20% | -4.68% | +8.12% | +12.61% | +14.92% | +84.55% | +205.18% | +5,665.71% | 56.16B | |
| +0.42% | +1.87% | +11.89% | +12.87% | +19.67% | +15.26% | +106.61% | -15.67% | +244.54% | 54.16B | |
| -3.43% | -4.78% | -1.06% | +11.87% | +18.01% | +22.89% | +50.15% | +2.75% | +270.80% | 45.33B | |
| +0.51% | -1.11% | +2.05% | +15.95% | +22.92% | +21.16% | +100.12% | +4.47% | +1,023.50% | 42.25B | |
| -0.53% | +1.01% | -7.98% | -1.71% | +137.14% | +220.84% | +929.32% | +506.94% | - | 40.78B | |
| +3.27% | +47.96% | +66.97% | +112.15% | +92.99% | +112.67% | +96.48% | +36.35% | +249.91% | 33.8B | |
| +1.22% | -1.39% | +7.10% | +6.44% | +11.15% | +13.92% | +46.95% | +16.23% | +160.92% | 32.25B | |
| -1.29% | -1.72% | -16.86% | +12.95% | +41.48% | +21.00% | -6.85% | -62.43% | - | 23.57B | |
| -1.25% | -0.06% | -10.41% | -5.15% | -7.49% | -15.86% | -5.56% | -67.90% | - | 22.39B | |
| +1.55% | +21.63% | -0.48% | +11.92% | -34.73% | -41.51% | +377.27% | +265.83% | +775.12% | 24.37B | |
| -3.26% | -2.06% | +5.00% | +13.33% | +16.69% | +12.93% | +171.06% | +189.48% | +2,158.49% | 18.95B | |
| -5.55% | +3.15% | +20.76% | +51.84% | +78.59% | +98.90% | +116.54% | -19.08% | +369.49% | 17.95B | |
| +0.73% | +3.57% | +16.96% | +27.87% | +40.58% | +44.70% | +87.72% | -15.33% | +111.94% | 16.88B | |
| +8.75% | +11.42% | +23.10% | +28.46% | +64.04% | +84.64% | +255.24% | +231.34% | +578.94% | 16.4B | |
| -0.49% | +3.35% | +10.40% | +0.18% | - | - | - | - | - | 16.62B | |
| -2.96% | +13.31% | +23.49% | +26.82% | +15.20% | +26.97% | -11.84% | -27.34% | +161.49% | 16.14B | |
| -4.03% | +2.59% | -0.42% | +10.19% | +180.86% | +166.14% | +341.90% | +1,407.09% | +787.81% | 15.77B | |
| -7.26% | +7.16% | -11.53% | +63.59% | +22.70% | -16.01% | - | - | - | 14.05B | |
| Average | -0.74% | +6.55% | +6.46% | +22.10% | +43.84% | +46.53% | +164.69% | +156.52% | +966.05% | 30.12B | |
| Weighted average by Cap. | -0.45% | +5.03% | +4.74% | +19.53% | +41.66% | +45.30% | +163.75% | +121.17% | +1,263.89% |
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
- Sector Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
